What’s New, What’s Next at Proscia for Life Sciences

Revolutionary advancements in technology and science have elevated digital pathology’s role in drug development, emerging at the forefront of AI-driven strategies to accelerate R&D from discovery to commercialization. As the industry advances, so do we—expanding our platform, AI capabilities, and real-world data solutions to empower life sciences organizations to drive breakthroughs faster than ever.

Join Proscia’s CEO and life sciences product leader for an exclusive discussion on the evolution of our solutions shaping the future of digital pathology in drug discovery and development. We’ll showcase our latest product updates and offer a preview of what’s ahead—all designed to help pharmaceutical companies, contract research organizations, and emerging biotechs advance their R&D with speed and precision.

Why Attend

• Get exclusive insights into our strategic vision for the future of digital pathology in life sciences and how our expanded product suite (including platform, RWD, and AI solutions) is helping our customers advance precision medicine
• Experience firsthand our latest Concentriq LS enhancements designed to accelerate your research
• Learn from platform best practices and live demos, ensuring your team maximizes the full potential of Concentriq LS
• Discover how our multimodal pathology RWD is powering breakthrough discoveries and advancing AI model development for therapeutic R&D
• Engage directly with our team through a Q&A session

Featured Speakers

David West
Chief Executive Officer
Proscia

Edaeni Hamid
Senior Product Director
Proscia

Register

SOURCE: Proscia